Next Article in Journal
Patellofemoral Pain Syndrome and Its Association with Hip, Ankle, and Foot Function in 16- to 18-Year-Old High School Students
Previous Article in Journal
Reliability and Validity of the INFOOT Three-Dimensional Foot Digitizer for Patients with Rheumatoid Arthritis
 
 
Journal of the American Podiatric Medical Association is published by MDPI from Volume 116 Issue 1 (2026). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with American Podiatric Medical Association.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Foot Biomechanics in Patients with Diabetes Mellitus

by
José Luis Lázaro-Martínez
*,
Francisco Javier Aragón-Sánchez
,
Juan Vicente Beneit-Montesinos
,
Maximo A. González-Jurado
,
Esther García Morales
and
David Martínez Hernández
Diabetic Foot Unit, University Podiatric Clinic, College of Podiatry, Universidad Complutense de Madrid, Madrid, Spain
*
Author to whom correspondence should be addressed.
J. Am. Podiatr. Med. Assoc. 2011, 101(3), 208-214; https://doi.org/10.7547/1010208
Published: 1 May 2011

Abstract

Background: We sought to identify the biomechanical characteristics of the feet of patients with diabetes mellitus and the interrelationship with diabetic neuropathy by determining the range of joint mobility and the presence and locations of calluses and foot deformities. Methods: This observational comparative study involved 281 patients with diabetes mellitus who underwent neurologic and vascular examinations. Joint mobility studies were performed, and deformities and hyperkeratosis locations were assessed. Results: No substantial differences were found between patients with and without neuropathy in joint mobility range. Neuropathy was seen as a risk factor only in the passive range of motion of the first metatarsophalangeal joint (mean ± SD: 57.2° ± 19.5° versus 50.3° ± 22.5°, P = .008). Mean ± SD ankle joint mobility values were similar in both groups (83.0° ± 5.2° versus 82.8° ± 9.3°, P = .826). Patients without neuropathy had a higher rate of foot deformities such as hallux abductus valgus and hammer toes. There was also a higher presence of calluses in patients without neuropathy (82.8% versus 72.6%; P = .039). Conclusions: Diabetic neuropathy was not related to limited joint mobility and the presence of calluses. Patients with neuropathy did not show a higher risk of any of the deformities examined. These findings suggest that the etiology of biomechanical alterations in diabetic people is complex and may involve several anatomically and pathologically predisposing factors.

Diabetic foot, a serious complication of diabetes mellitus, has an incidence rate of 1% in northern European countries to 11% on the African continent, accounting for a high social, economic, and health-care cost. [1] One of the most devastating complications of diabetes is limb amputation. Amputations are preceded by an ulcer [2] in approximately 85% of cases, and diabetes is involved in 40% to 70% of nontraumatic amputations. [3]
Diabetic foot conditions develop due to two principal causes—neuropathic and vascular—which lead to a foot lesion [4] when they are combined with an external or internal trauma. Ulcers are mainly caused by diabetic polyneuropathy associated with the risk of a loss of protective foot sensation when traumas take place. [4] Other neuropathy-related factors that increase the risk of foot ulcers, such as orthopedic deformities and biomechanical alterations (because motor functions are affected), have been identified. [5]
Currently, we know that peripheral diabetic neuropathy affects the sensitive and motor functions, as well as the autonomic functions, [6] although its implications and onset have not been defined clearly in diabetic foot syndrome. It has been ascertained that diabetes affects the biomechanics of patients’ feet in several ways. On the one hand, the nonenzymatic glycation of type I collagen [7] is believed to cause limited joint mobility, especially in the ankle joint and the first metatarsophalangeal joint [811]; on the other hand, motor neuropathy is believed to cause deformities because the mechanical balance between the extrinsic and intrinsic musculature of the foot is altered. [1214] It has been suggested that limited joint mobility associated with deformities increases plantar pressures in the diabetic foot, thus causing overloads that may lead first to plantar hyperkeratosis and, subsequently, to neuropathic ulcer. [15,16]
However, several articles pointing to controversies in the assumptions of the aforementioned paradigms have been published. It is believed that a neuropathic ulcer [17] cannot be explained by plantar pressure alone and that the relationship between deformities and neuropathies does not seem to be well established either. [12,18] Some researchers [12,13] have demonstrated, with nuclear magnetic resonance studies, that the intrinsic weakening of the foot musculature, as suggested by the volume reduction of the lumbrical and interosseous muscles, was present in diabetic patients regardless of the presence of neuropathy.
There is no accurate evidence of diabetes causing limitations to the ankle joint [19] or the first metatarsophalangeal joint [20] because these conditions are widespread in the general population, particularly in the age groups in which type 2 diabetes mellitus manifests for the first time. [21]
This study aims to identify the biomechanical characteristics of diabetic patients with and without neuropathy by determining the range of joint movement and by monitoring the rate and distribution of calluses and identifying any orthopedic foot deformities.

Methods

An observational comparative study was performed of 281 patients enrolled from the Diabetic Foot Unit of the Complutense University of Madrid between July 1, 2007, and September 30, 2008, and from the Manzanares Diabetic Patients Association (Ciudad Real, Spain) during visits made in July and October 2007. People volunteering from the Diabetic Patients Association were included in the study for the purpose of selecting patients outside of the clinic who normally did not visit their physician with concerns about foot abnormalities.
Patients with diabetes mellitus older than 18 years and without active ulcers were recruited. Patients who had undergone major amputation, those who had Charcot’s foot, those in wheelchairs, bedridden patients, and those who needed walking aids (eg, crutches or splints) were excluded from the study. Patients with the following vascular conditions were also excluded: ankle-brachial index less than 0.5 or transcutaneous oxygen pressure less than 30 mm Hg or the absence of both distal pulses (the posterior tibial pulse and the pedis pulse).
All of the patients underwent a neurologic examination using a 5.07 Semmes-Weinstein monofilament 10 g and a biothesiometer (both from Novalab Ibérica, Madrid). The threshold established for the Semmes-Weinstein monofilament was when the patient did not feel the filament in more than four of the ten examined points. [22] The foot points examined were the plantar surface of the first, third, and fifth toes; the plantar aspect of the first, third, and fifth metatarsal heads; the internal and lateral plantar surfaces in the midfoot; the plantar surface of the heel; and the dorsum of the foot, between the first and second toes. Vibratory sensibility was considered to be affected if the patient did not feel the vibration of the instrument’s head when voltages greater than 25 V were applied. [23] Biothesiometers were applied to both maleoli, the first and fifth metatarsal heads, and the bony prominence of the first interphalangeal joint in the hallux. Vibratory sensibility was considered to be affected when the patient did not feel the biothesiometer in the hallux. [24] Patients were considered to have neuropathy when they did not perceive these two examined sensibilities [25] (Semmes-Weinstein monofilament and biothesiometer; n = 124). The control group was comprised of patients who had normal perception of the two described tests (n = 157). Patients who had loss of sensation in only one of the neurologic states examined were excluded.
Joint mobility was measured in the ankle joint, the first metatarsophalangeal joint, the subtalar joint, the relaxed calcaneal stance position, and the neutral calcaneal stance position. [26,27] The ankle joint was examined with the patient supine and the ankle joint in the neutral position; a vertical line was marked on the patient’s skin from heel to midcalf, and the maximum range of talar extension in passive motion was measured in degrees with a goniometer. The reference value for the ankle joint was greater than 90° of dorsiflexion.
The passive range of movement of the first metatarsophalangeal joint was examined with the patient also in the supine position, and a horizontal line was drawn from the big toe to the heel. The maximum range of passive extension to plantarflexion was recorded. The reference value of movement in off-loading is greater than 65°. The same range was explored with the patient standing. The reference value in loading is greater than 30°.
Subtalar joint movements (inversion and eversion) were examined with the patient in the prone position, holding the calcaneus with one hand and the talar head/neck with the thumb and index finger of the other hand. Holding the talus rather than the tibia isolated the subtalar joint from ankle motion; adduction and abduction movements with the hand on the calcaneus were applied. Reference values were considered to be 20° in inversion and 10° in eversion.
Relaxed calcaneal stance position was measured by bisecting the posterior surface of the calcaneus while the patient was in a standing position. The angle that this line made with the ground was recorded with a goniometer. The reference value was 2° to 3°. Neutral calcaneal stance position was measured by placing the foot into its neutral position. The reference value was assumed to be between neutral and 3° of varus.
The following deformities were registered: hallux abducto valgus, hammer toes, claw toes, crowded toes (supraductus or infraductus), and tailor’s bunions. Hallux abducto valgus was defined as disruption of the first metatarsophalangeal joint with lateral deviation of the hallux, frequently associated with a bunion. Hammer toes were considered only when the proximal phalanx was extended. Claw toes were defined when the metatarsophalangeal joint was in dorsiflexion and the proximal and distal interphalangeal joints were in plantarflexion. Crowded toes were the deformities that associated a hyperextension of the metatarsophalangeal joint with a varus or valgus rotation, which situated the toe above (supraductus) or below (infraductus) the contralateral toe. Tailor’s bunion was considered as a prominence at the lateral aspect of the fifth metatarsal head with the fifth toe deflected to varus.
Thickened skin resulting from abnormal loading as a consequence of biomechanical alterations was defined as a callus. The locations of the calluses were defined according to the anatomical areas in which they appeared. The assessments of joint mobility and deformities were performed by the same examiner (J.L.L.), who has extensive experience in such clinical aspects.
The statistical analysis was performed with SPSS version 15.0 for Windows (SPSS Inc, Chicago, Illinois). The Student t test for independent samples was performed to compare the medium in quantitative variables. The χ2 statistical test was used to identify differences in the proportions of qualitative variables. Odds ratios and their 95% confidence intervals were determined through a univariate and multivariate logistic regression model. A significant 5% difference was assumed for a type I error (P < .05).
All of the patients agreed to participate in this study by signing an informed consent form. This study was approved by the ethics committee of Madrid’s San Carlos Clinical University Hospital on July 2, 2007.

Results

The patient characteristics are summarized in Table 1. The results show limited joint mobility compared with the reference values [26,27] of most of the joints examined in both study groups. However, there was a higher level of limited joint mobility in the case of the first metatarsophalangeal joint when the patient was resting and in inversion of the subtalar joint in the neuropathic patient group (P < .05) (Table 2).
Hallux abducto valgus (P = .001) and hammer toes (P = .027) were significantly more frequent in patients without neuropathy. Claw toes were more frequently found in neuropathic patients, but the difference was not significant (P = .06). Neuropathic patients did not show a higher rate of foot deformities compared with nonneuropathic patients for the other deformities studied (Table 3).
Of the 281 diabetic patients, 130 of 157 without neuropathy (82.8%) and 90 of 124 with neuropathy (72.6%) had calluses. Calluses were more frequent in diabetic patients unaffected by neuropathy (P = .039) (Table 4). A multivariate logistic regression model was constructed using the significant variables from the univariate analysis. Table 5 summarizes the effect of the following variables: sex, age, duration of diabetes in years, and neuropathy.

Discussion

The results of this study show that patients with diabetes mellitus experience limited joint mobility in all of the examined foot joints. However, no substantial differences were found between patients with and without neuropathy. Neuropathy was seen as a risk factor only in the range of movement of the first metatarsophalangeal joint with the patient resting (mean ± SD: 57.2° ± 19.5° versus 50.3° ± 22.5°, P = .008). Other authors [11,18] have found that limitation of the first metatarsophalangeal joint was present in almost 50% of their patients. The limitation of the first metatarsophalangeal joint (when loading <30°, and 60° offloading) has been identified as a risk factor that can lead to ulcers in the medial plantar area of the hallux or in the central metatarsals as a result of a pressure transfer syndrome. However, this relationship has recently been disputed because no cross-link has been found between hallux ulcers and limited mobility in this joint. There were other patients with the same limited mobility who developed ulcers in other foot areas. [18]
Table 1. Descriptive Characteristics of the 281 Study Patients
Table 1. Descriptive Characteristics of the 281 Study Patients
Japma 101 00208 i001
Table 2. Examined Joint Mobility Ranges in Both Patient Groups
Table 2. Examined Joint Mobility Ranges in Both Patient Groups
Japma 101 00208 i002
The values of ankle joint mobility were similar in both groups (83.0° ± 5.2° versus 82.8° ± 9.3°; P = .826). The limited dorsal flexion of the ankle joint has been described by several authors, [5,9] and, subsequently, several research studies [8,10] have identified a tendency in patients with neuropathy to develop a functional clubfoot that would raise the pressure in the forefoot, thus increasing the risk of ulcers in this area. In the present study, neuropathy was not associated with a higher rate of limited mobility in this joint. Most of the research performed to assess limited joint mobility in the feet of patients with neuropathy is retrospective and examines the feet after they have experienced a lesion, when their joint mobility has been reduced (probably as a result of long-lasting treatments involving immobilization and off-loading of the feet while healing the ulcer, which, on average, takes 8–12 weeks in the case of neuropathic ulcers).
Table 3. Foot Deformities in Both Patient Groups
Table 3. Foot Deformities in Both Patient Groups
Japma 101 00208 i003
As to the presence of deformities, we observed that patients without neuropathy were more prone to foot deformities, although in some cases, eg, hallux abducto valgus and hammer toes, neuropathy was not found to be a risk factor (hallux abducto valgus: odds ratio = 0.4, P = .001; and hammer toes: odds ratio = 0.413, P = .027). Only patients with neuropathy seemed to be more prone to claw toes compared with those who did not have claw toes caused by neuropathy (48.4% versus 59.7%; P = .06), although no significant statistical differences were found. Digital deformities in patients who already had diabetes before the onset of neuropathy have been described by Greenman et al, [13] proving, through nuclear magnetic resonance studies, that the lumbrical and interosseous muscular volume of patients with diabetes mellitus decreased compared with that of healthy patients and that this alteration is more severe in patients with neuropathy. Similar research studies [12] have demonstrated a relationship between the effect on the weakness of intrinsic musculature and diabetic foot neuropathy, but according to statistical models, this occurs in only approximately 36% of patients. As for the present research study, in the multivariate logistic regression model, the only deformity that seemed to be closely linked to diabetes was tailor’s bunion (odds ratio = 1.051, P = .017), although it had a low value. Recently, Bus et al [28] suggested that the role of these muscle factors in claw toe development may not be primary or as straightforward as previously believed.
Table 4. Locations of Calluses in Neuropathic and Nonneuropathic Patients’ Feet
Table 4. Locations of Calluses in Neuropathic and Nonneuropathic Patients’ Feet
Japma 101 00208 i004
There was a higher presence of calluses in patients without neuropathy (82.8% versus 72.6%; P = .039), and, surprisingly, the appearance of calluses in the plantar zone of the hallux was more frequent in patients without neuropathy (25.5% versus 14.5%, odds ratio = 0.497, P = .024). Until recently, the presence of calluses had been assumed to be more frequent in patients with neuropathy, but these findings may be due to the fact that patients with neuropathy do not feel pain and calluses are more evident; however, it does not mean that calluses are more prevalent. [11,16,18]
In the multivariate logistic regression model, women had a greater risk factor in terms of experiencing calluses in the plantar area of the hallux (expB = 2.787, P = .001), in the central metatarsal plantar area (expB = 1.909, P = .01), and in the dorsum of the fifth toe (expB = 2.673, P = .001). This higher tendency in females to have calluses is probably related to the use of narrow-heeled shoes rather than to diabetes. [29]
Similar to previous studies, [8,9,16,17] we believe that limitations related to the diagnosis criteria of neuropathy in the present study can be found. We defined a “neuropathic patient” as one who does not feel the vibration higher than 25 V with the biothesiometer and does not feel the light touch with the Semmes-Weinstein monofilament. Motor and autonomic neuropathy should be addressed in future trials for a better classification of the patient and to associate each alteration with the biomechanical characteristics.
Table 5. Summary Table of the Multivariate Logistic Regression Model Encompassing the Variables that Were Considered to Affect the Dependent Variable
Table 5. Summary Table of the Multivariate Logistic Regression Model Encompassing the Variables that Were Considered to Affect the Dependent Variable
Japma 101 00208 i005
The differences found in the present study compared with previous studies can probably be explained by the fact that individuals who did not usually visit the podiatric physician or the general physician to treat their foot problems were enrolled in the research, the main limitation of which was the lack of healthy patients in the same age range. However, it is logical to think that the age of individuals who develop type 2 diabetes means it is difficult to find patients with healthy feet. Most of the population experiences some type of biomechanical alteration [22] because they use the wrong shoes and because of the lack of childhood prevention plans for foot abnormalities.
The main biomechanical alterations in diabetic patients’ feet are currently considered to be attributable to the neuropathy, and deformities are, thus, classified as a further risk of this condition, and it is assumed to be one of its consequences. [30] However, these paradigms have been described in previous studies that classified patients only according to sensory diabetic neuropathy. [8,9,16,17] In the present study, we have the same limitation because the autonomic and motor aspects of diabetic neuropathy were not measured. New prospective studies are probably necessary to address the biomechanical alterations in the diabetic population, and we would define which conditions could be considered due to the neuropathy or due to pathomechanical conditions of the foot.
We have not addressed in the present study the lifestyle of these patients, especially in relation to activity patterns. Sport practice, type of job, or sedentary lifestyle may affect limited joint mobility and other biomechanics characteristics. Furthermore, another limitation in this study is that we did not acquire a systematic foot radiograph in these patients. Bone abnormalities, joint inflammatory disease, and other causes of limitations in pedal joint range of motion could have been found.
We believe that in diabetic patients, onset of the disease does not occur with a healthy foot, or at least not in most cases, and, therefore, the diagnosis should be linked to a biomechanical foot examination to promptly identify any ulcer risk factors, such as limited joint mobility, deformities, hyperkeratosis, and areas at risk for lesions.
Broadening research studies to examine all of the mechanical alteration variables jointly and extending research to patient groups without diabetes in the same age range will allow us to improve the knowledge available on the development of foot deformities.

Financial Disclosure

None reported.

Conflicts of Interest

None reported.

References

  1. Boulton, AJ, LVileikyte, GRagnarson-Tennvall, et al: The global burden of diabetic foot disease. Lancet 366: 1719, 2005.
  2. Pecoraro, RE, GEReiber, and EMBurgess: Pathways to diabetic limb amputation: basis for prevention. Diabetes Care 13: 513, 1990.
  3. Apelqvist, J and JLarsson: What is the most effective way to reduce incidence of amputation in the diabetic foot?Diabetes Metab Res Rev 16 ( suppl 1:):S75, 2000.
  4. Jeffcoate, WJ and KGHarding: Diabetic foot ulcers. Lancet 361: 1545, 2003.
  5. Mueller, MJ, MHastings, PKCommean, et al: Forefoot structural predictors of plantar pressures during walking in people with diabetes and peripheral neuropathy. J Biomech 36: 1009, 2003.
  6. Boulton, AJ: The diabetic foot: an update. Foot Ankle Surg 14: 120, 2008.
  7. Reihsner, R, MMelling, WPfeiler, et al: Alterations of biochemical and two-dimensional biomechanical properties of human skin in diabetes mellitus as compared to effects of in vitro non-enzymatic glycation. Clin Biomech (Bristol, Avon) 15: 379, 2000.
  8. Zimny, S, HSchatz, and MPfohl: The role of limited joint mobility in diabetic patients with an at-risk foot. Diabetes Care 27: 942, 2004.
  9. Fernando, DJ, EAMasson, AVeves, et al: Relationship of limited joint mobility to abnormal foot pressures and diabetic foot ulceration. Diabetes Care 14: 8, 1991.
  10. Van Gils, CC and BRoeder: The effect of ankle equinus upon the diabetic foot. Clin Podiatr Med Surg 19: 391, 2002.
  11. Boffeli, TJ, JKBean, and JRNatwick: Biomechanical abnormalities and ulcers of the great toe in patients with diabetes. J Foot Ankle Surg 41: 359, 2002.
  12. Bus, SA, QXYang, JHWang, et al: Intrinsic muscle atrophy and toe deformity in the diabetic neuropathic foot: a magnetic resonance imaging study. Diabetes Care 25: 1444, 2002.
  13. Greenman, RL, LKhaodhiar, CLima, et al: Foot small muscle atrophy is present before the detection of clinical neuropathy. Diabetes Care 28: 1425, 2005.
  14. Andersen, H, MDGjerstad, and JJakobsen: Atrophy of foot muscles: a measure of diabetic neuropathy. Diabetes Care 27: 2382, 2004.
  15. Lobmann, R, GKasten, UKasten, et al: Association of increased plantar pressures with peripheral sensorimotor and peripheral autonomic neuropathy in Type 2 diabetic patients. Diabetes Nutr Metab 15: 165, 2002.
  16. Murray, HJ, MJYoung, SHollis, et al: The association between callus formation, high pressures and neuropathy in diabetic foot ulceration. Diabet Med 13: 979, 1996.
  17. Armstrong, DG, EJPeters, KAAthanasiou, et al: Is there a critical level of plantar foot pressure to identify patients at risk for neuropathic foot ulceration. ?J Foot Ankle Surg 37: 303, 1998.
  18. Nube, VL, LMolyneaux, and DKYue: Biomechanical risk factors associated with neuropathic ulceration of the hallux in people with diabetes mellitus. JAPMA 96: 189, 2006.
  19. Gutierrez, EM, MDHelber, DDealva, et al: Mild diabetic neuropathy affects ankle motor function. Clin Biomech (Bristol, Avon) 16: 522, 2001.
  20. Wrobel, JS, NJBirkmeyer, JLDercoli, et al: Do clinical examination variables predict high plantar pressures in the diabetic foot. ?JAPMA 93: 367, 2003.
  21. Hill, RS: Ankle equinus: prevalence and linkage to common foot pathology. JAPMA 85: 295, 1995.
  22. Armstrong, DG: The 10-g monofilament: the diagnostic divining rod for the diabetic foot. ?Diabetes Care 23: 887, 2000.
  23. Boulton, AJ, DBKubrusly, JHBowker, et al: Impaired vibratory perception and diabetic foot ulceration. Diabet Med 3: 335, 1986.
  24. Feldman, EL and MJStevens: Clinical testing in diabetic peripheral neuropathy. Can J Neurol Sci 21: S3, 1994.
  25. Lavery, LA, DGArmstrong, RPWunderlich, et al: Predictive value of foot pressure assessment as part of a population-based diabetes disease management program. Diabetes Care 26: 1069, 2003.
  26. Michaud, TC: “Ideal Motions During the Gait Cycle,”. inFoot Orthoses and Other Forms of Conservative Foot Care. , p27. ,Lippincott Williams & Wilkins. ,Philadelphia. ,1993.
  27. Aström, M and TArvidson: Alignment and joint motion in the normal foot. J Orthop Sports Phys Ther 22: 216, 1995.
  28. Bus, SA, MMaas, RPMichels, et al: Role of intrinsic muscle atrophy in the etiology of claw toe deformity in diabetic neuropathy may not be as straightforward as widely believed. Diabetes Care 32: 1063, 2009.
  29. Menz, HB and MEMorris: Footwear characteristics and foot problems in older people. Gerontology 51: 346, 2005.
  30. Apelqvist, J, KBakker, WHVan Houtum, et al: Practical guidelines on the management and prevention of the diabetic foot: based upon the International Consensus on the Diabetic Foot (2007): prepared by the International Working Group on the Diabetic Foot. Diabetes Metab Res Rev 24 ( suppl 1:):S181, 2008.

Share and Cite

MDPI and ACS Style

Lázaro-Martínez, J.L.; Aragón-Sánchez, F.J.; Beneit-Montesinos, J.V.; González-Jurado, M.A.; Morales, E.G.; Hernández, D.M. Foot Biomechanics in Patients with Diabetes Mellitus. J. Am. Podiatr. Med. Assoc. 2011, 101, 208-214. https://doi.org/10.7547/1010208

AMA Style

Lázaro-Martínez JL, Aragón-Sánchez FJ, Beneit-Montesinos JV, González-Jurado MA, Morales EG, Hernández DM. Foot Biomechanics in Patients with Diabetes Mellitus. Journal of the American Podiatric Medical Association. 2011; 101(3):208-214. https://doi.org/10.7547/1010208

Chicago/Turabian Style

Lázaro-Martínez, José Luis, Francisco Javier Aragón-Sánchez, Juan Vicente Beneit-Montesinos, Maximo A. González-Jurado, Esther García Morales, and David Martínez Hernández. 2011. "Foot Biomechanics in Patients with Diabetes Mellitus" Journal of the American Podiatric Medical Association 101, no. 3: 208-214. https://doi.org/10.7547/1010208

APA Style

Lázaro-Martínez, J. L., Aragón-Sánchez, F. J., Beneit-Montesinos, J. V., González-Jurado, M. A., Morales, E. G., & Hernández, D. M. (2011). Foot Biomechanics in Patients with Diabetes Mellitus. Journal of the American Podiatric Medical Association, 101(3), 208-214. https://doi.org/10.7547/1010208

Article Metrics

Back to TopTop